Jerome Amir Singh

From IntactiWiki
Jump to navigation Jump to search

Jerome Amir Singh is member of the 2018 Guideline Development Group (GDG) of the WHO. The GDG's task is to develop updated recommendations on safe male circumcision for HIV prevention and related service delivery for adolescent boys and men in generalized HIV epidemics.[1]

Contents

Biography

The WHO published the following biography of Jerome Amir Singh:

Singh, Jerome Amir

Jerome Amir Singh (BA[a 1], LLB, LLM, MHSc, Ph.D.[a 2]) is Head of Ethics and Law at the Centre for the AIDS Programme of Research in South Africa (CAPRISA), and the Director of the Ethical, Legal, and Social Issues (ELSI) Advisory Services on Global Health Research and Development, funded by the Bill and Melinda Gates Foundation. He is also Adjunct Professor in the Dalla Lana School of Public Health at the University of Toronto, Canada. He has served as an ad hoc Consultant to several UN entities, including the WHO, UNAIDS, UNICEF, the Special Programme for Research and Training in Tropical Diseases (WHO-TDR), and the United Nations Interregional Crime and Justice Research Institute (UNICRI). He is the Co-Chairperson of the HIV Prevention Trial Network’s (HPTN) Ethics Working Group, and a member of the HIV Vaccine Trial Network’s (HVTN) Efficacy Trial Working Group. He is a member of the South African National AIDS Council (SANAC) Technical Task Team on Ensuring Protection of Human Rights and Improving Access to Justice. He currently serves on several oversight bodies, including the International Ethics Review Board of Médecins Sans Frontières (MSF) and the Research Ethics Committee of the Human Sciences Research Council of South Africa.[2]

Singh is a lawyer who works for several different organizations, including some funded by the Bill & Melinda Gates Foundation and the U. S. National Institutes of Health.[3] One cannot imagine that he could hold these positions without being biased in favor of non-therapeutic circumcision.

Population-based studies

September 2021 saw the publication of two huge population studies on the relationship of circumcision and HIV infection:

  1. Mayan et al. (2021) carried out a massive empirical study of the male population of the province of Ontario, Canada (569,950 males), of whom 203,588 (35.7%) were circumcised between 1991 and 2017. The study concluded that circumcision status is not related to risk of HIV infection.[4]
  2. Morten Frisch & Jacob Simonsen (2021) carried out a large scale empirical population study in Denmark of 855,654 males regarding the alleged value of male circumcision in preventing HIV and other sexually transmitted infections in men. They found that circumcised men have a higher rate of STI and HIV infection overall than intact men.[5]

No association between lack of circumcision and risk of HIV infection was found by either study. There now is credible evidence that the massive, expensive African circumcision programs have not been effective in preventing HIV infection.

See also

Abbreviations

  1. ↑ a b   Bachelor of Arts, Wikipedia. Retrieved 13 October 2021. (BA or AB; from the Latin baccalaureus artium or artium baccalaureus.)
  2. ↑ a b   Doctor of Philosophy, Wikipedia. Retrieved 16 June 2021. (Also abbreviated as D.Phil.)

References

  1. ↑   (May 2018). WHO to develop new guidelines on male circumcision. Retrieved 26 March 2020.
  2. ↑   Biographies of Guideline Development Group (GDG) members for WHO guidance  , WHO. (September 2018). Retrieved 26 March 2020.
  3. ↑   Professor Jerome Singh. Retrieved 4 April 2020.
  4. ↑   Mayan M, Hamilton RJ, Juurlink DN, Austin PC, Jarvi KA. Circumcision and Risk of HIV Among Males From Ontario, Canada. J Urol. 23 September 2021; PMID. DOI. Retrieved 21 August 2022.
    Quote: We found that circumcision was not independently associated with the risk of acquiring HIV among men from Ontario, Canada.
  5. ↑   Frisch M, Simonsen J. Non-therapeutic male circumcision in infancy or childhood and risk of human immunodeficiency virus and other sexually transmitted infections: national cohort study in Denmark. Eur J Epidemiol. 26 September 2021; 37: 251–9. PMID. DOI. Retrieved 16 January 2022.
Retrieved from "https://en.intactiwiki.org/w/index.php?title=Jerome_Amir_Singh&oldid=39148"